Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057107312032v1
13/2/142    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chung, N.
Right arrow Articles by Strulovici, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, N.
Right arrow Articles by Strulovici, B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An Efficient and Fully Automated High-Throughput Transfection Method for Genome-Scale siRNA Screens

Namjin Chung

Department of Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania, namjin.chung{at}bms.com

Louis Locco

Department of Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

Kevin W. Huff

Department of Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

Steven Bartz

Department of Biology, Rosetta Inpharmatics, a wholly owned subsidiary of Merck & Co., Inc., Seattle, Washington

Peter S. Linsley

Department of Biology, Rosetta Inpharmatics, a wholly owned subsidiary of Merck & Co., Inc., Seattle, Washington

Marc Ferrer

Department of Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania, marc_ferreralegre{at}merck.com

Berta Strulovici

Department of Automated Biotechnology, Merck Research Laboratories, North Wales, Pennsylvania

RNA interference (RNAi), combined with the availability of genome sequences, provides an unprecedented opportunity for the massive and parallel investigations of gene function. Small interfering RNA (siRNA) represents a popular and quick approach of RNAi for in vitro loss-of-function genetic screens. Efficient transfection of siRNA is critical for unambiguous interpretation of screen results and thus overall success of any siRNA screen. A high-throughput, lipid-based transfection method for siRNA was developed that can process eighty 384-well microplates in triplicate (for a total of 30,720 unique transfections) in 8 h. Transfection throughput was limited only by the speed of robotics, whereas the cost of screening was reduced. As a proof of principle, a genome-scale screen with a library of 22,108 siRNAs was performed to identify the genes sensitizing cells to mitomycin C at concentrations of 0, 20, and 60 nM. Transfection efficiency, performances of control siRNAs, and other quality metrics were monitored and demonstrated that the new, optimized transfection protocol produced high-quality results throughout the screen. (Journal of Biomolecular Screening 2008:142-148)

Key Words: RNAi • RNA interference • siRNA • transfection • high-throughput screen • functional genomics • automation

This version was published on February 1, 2008

Journal of Biomolecular Screening, Vol. 13, No. 2, 142-148 (2008)
DOI: 10.1177/1087057107312032
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?